首页> 美国卫生研究院文献>Pharmaceutics >Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems
【2h】

Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems

机译:乳腺癌中化疗的抵抗机制及药物递送系统中可能的靶标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Breast cancer (BC) is one of the most important cancers worldwide, and usually, chemotherapy can be used in an integrative approach. Usually, chemotherapy treatment is performed in association with surgery, radiation or hormone therapy, providing an increased outcome to patients. However, tumors can develop resistance to different drugs, progressing for a more aggressive phenotype. In this scenario, the use of nanocarriers could help to defeat tumor cell resistance, providing a new therapeutic perspective for patients. Thus, this systematic review aims to bring the molecular mechanisms involved in BC chemoresistance and extract from the previous literature information regarding the use of nanoparticles as potential treatment for chemoresistant breast cancer.
机译:乳腺癌(BC)是全球最重要的癌症之一,通常,化疗可以以综合方法使用。通常,化疗治疗与手术,辐射或激素治疗相关联,为患者提供了增加的结果。然而,肿瘤会对不同的药物产生抗性,进展更具侵略性的表型。在这种情况下,使用纳米载体可以有助于打败肿瘤细胞抗性,为患者提供新的治疗性观点。因此,这种系统评价旨在使来自BC ChemoTationisce的分子机制和提取来自先前文献信息的关于使用纳米颗粒作为化学乳腺癌的潜在治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号